Broker Research
June 11, 2025 / 10:11 IST
Reported Standalone quarterly numbers for OXYGENTA PHARMACEUTICAL are:Net Sales at Rs 49.47 crore in March 2025 up 368.77% from Rs. 10.55 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.15 crore in March 2025 down 126.86% from Rs. 8.02 crore in March 2024.
EBITDA stands negative at Rs. 1.63 crore in March 2025 down 1.87% from Rs. 1.60 crore in March 2024.
OXYGENTA PHARMA shares closed at 121.07 on June 10, 2025 (BSE) and has given 30.59% returns over the last 6 months and 264.67% over the last 12 months.
| OXYGENTA PHARMACEUTICAL | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 49.47 | 33.21 | 10.55 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 49.47 | 33.21 | 10.55 | | EXPENDITURE | | Consumption of Raw Materials | 44.03 | 37.61 | 9.04 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.24 | -5.76 | -2.12 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.19 | 1.83 | 5.25 | | Depreciation | -0.23 | 0.71 | 0.64 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.17 | 3.88 | 0.00 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.45 | -5.06 | -2.25 | | Other Income | 0.05 | 0.49 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -1.40 | -4.57 | -2.24 | | Interest | 2.13 | 0.39 | 0.59 | | P/L Before Exceptional Items & Tax | -3.53 | -4.96 | -2.83 | | Exceptional Items | -0.27 | -- | 0.25 | | P/L Before Tax | -3.80 | -4.96 | -2.59 | | Tax | -1.65 | -1.03 | -10.60 | | P/L After Tax from Ordinary Activities | -2.15 | -3.93 | 8.02 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.15 | -3.93 | 8.02 | | Equity Share Capital | 36.98 | 36.98 | 33.48 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.60 | -1.07 | 2.55 | | Diluted EPS | -0.60 | -1.12 | 2.44 | | EPS After Extra Ordinary | | Basic EPS | -0.60 | -1.07 | 2.55 | | Diluted EPS | -0.60 | -1.12 | 2.44 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
